I would say that in a lot of instances we actually know more than is typical. So yeah, a decent amount of info. But in the case of a subject matter specific quiet period, for a company that really has just one product currently moving forward, and it is FDA pre-approval, of course you’re definitely not going to get updates.
Market Data 
Markets 
AI
